Jubilant Pharmova | JUBLPHARMA | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
7,376
8,591
9,038
12,105
8,711
Cash flow Operating Act...
Cash flow Operating Activities
12,68513,03211,21515,42917,843
Investments in PPE
Investments in PPE
-4,642-4,891-6,481-5,742-5,275
Cash flow Investing Act...
Net cash used for Investment Activities
-4,504-6,177-10,118-3,270-7,390
Dividend Paid
Dividend Paid
5595605461,52815
Cash flow Financing Act...
Net cash provided by Financing Activities
-6,859-9,0116,574-10,504-17,094
Cash at beginning of period
Cash at beginning of period
3,3934,5642,44210,05412,308
Cash at end of period
Cash at end of period
4,5642,44210,05412,3085,020
Free Cash Flow
Free Cash Flow
8,043
8,141
4,734
9,688
12,568